Seasonal Influenza Vaccine Provides Priming for A/H1N1 Immunization
- 23 December 2009
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 1 (12) , 12re1
- https://doi.org/10.1126/scitranslmed.3000564
Abstract
Tests in ferrets show that the vaccine now used for mass inoculation against H1N1 is more effective when coinjected with an oil-in-water adjuvant and after the animals’ exposure to seasonal flu vaccine.Keywords
This publication has 9 references indexed in Scilit:
- A Novel Influenza A (H1N1) Vaccine in Various Age GroupsNew England Journal of Medicine, 2009
- Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted VaccineNew England Journal of Medicine, 2009
- Response to a Monovalent 2009 Influenza A (H1N1) VaccineNew England Journal of Medicine, 2009
- Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza VirusNew England Journal of Medicine, 2009
- Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in FerretsScience, 2009
- Pandemic Potential of a Strain of Influenza A (H1N1): Early FindingsScience, 2009
- Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccineProceedings of the National Academy of Sciences, 2009
- Animal models in influenza vaccine testingExpert Review of Vaccines, 2008
- MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profileExpert Review of Vaccines, 2003